http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004265299-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
filingDate 2002-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_278cee622ac6c190a6dd712bffa59f80
publicationDate 2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2004265299-A1
titleOfInvention Oral pharmaceutical formulation containing active carbon and use of the same
abstract This invention relates to use of activated charcoal in oral drug preparation for hyperthyroidism therapy. There is no side effect after taking oral drug preparation of activated charcoal in hyperthyroidism patients. Activated charcoal is in particle form not decomposed in human's intestinal tract and cannot be absorbed into blood while depressing serum thyroid hormones level rapidly. It is available completely in all kinds of clinical conditions when there are contraindications of antithyroid drugs and antithyroid drugs can not work promptly.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110151792-A
priorityDate 2001-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5554370-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228155172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227373312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54542717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID630
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227143439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398302
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10482895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127394906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87204053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129890600

Total number of triples: 47.